Over your lifetime, you shed around 100 pounds of skin cells.

Most of it comes off in microscopic flakes, which means a decent chunk of the dust in your house is basically just old you.

You’re not living there alone. Your exoskeleton is staying behind rent-free.

Also, ew.

What’s in store:

Read Time: 5 minutes

GOOGLE

Thomas Jefferson, resolve this thread

Google has released a new ad imagining the Declaration of Independence as a very modern group project.

The ad shows a fictional Thomas Jefferson working on the draft while Ben Franklin chases him over text.

Soon, the founders are editing in Google Docs, scheduling a Google Calendar meeting, joining a Google Meet call with cameras off, and signing the document digitally before the fireworks begin.

AI also appears, because apparently even 1776 needs a chatbot now.

The founders use Google’s “help me visualise” tool for the national seal, Gemini takes meeting notes, and the group asks it for advice before rejecting King George III’s document access request.

The key bits:

Revolutionary admin

The ad is meant to be playful, and the AI push is fairly light compared with other recent tech ads.

It also avoids suggesting AI could have written or improved the Declaration itself, which is probably for the best.

Reaction has been mixed. YouTube and Instagram comments seem mostly positive, while Bluesky users have been more critical, calling the ad “cringey” and “tone deaf.”

Much of the backlash focused on the AI angle, although historian Angus Johnston pointed out that surprisingly little of the ad is actually about AI.

I preferred Hamilton. - MV

Vote for live results + see results and opinions from yesterday at the bottom of the email.

AI SKILLS

11 Claude Code Skills That Turn AI Into Your Personal Content Machine

Most people use Claude for one-off drafts. Kieran Flanagan, HubSpot's SVP of Marketing, built 11 reusable skills that make Claude do the whole job — research, ideation, and execution.

The result is a content engine that runs while you focus on literally anything else.

Get instant access to:

One setup. Endless content output.

Number Crunch

Which number comes next in this sequence: 25, 17, 10, 4, ...

Find the answer at the bottom of the email!

That’s Weird

One university decided the final exam should be Claude’s problem

A professor at Fudan University in Shanghai flipped the final exam on its head by making students write questions designed to break AI, instead of answering them. Their targets were Claude, DeepSeek, and MiniMax, and the better the models performed, the worse the students’ grades.

Almost every student managed to trip up at least one model, but barely anyone could do it consistently, which was kind of the point. The takeaway was not “AI is dumb,” but that the real skill now is knowing how to judge AI, test it, and catch where it falls apart, because apparently the final boss of university is now grading the robot.

ANTHROPIC

Can Claude help discover treatments?

Anthropic has launched Claude Science, a new AI workbench for scientists.

It brings research tools, data and visuals into one place, making it easier for teams to organise and present their work.

The company says Claude Science could help speed up scientific research and support new healthcare treatments.

It also said several biotech and pharma companies are already using Claude.

But Anthropic is going further than just selling software. Its head of life sciences said the company wants to help discover treatments for “neglected” diseases.

That is a big move.

Most AI companies are building tools for drugmakers, while Anthropic is saying it may work on drug discovery itself.

This puts it in the same race as AI biotech startups, Big Pharma and companies like Google DeepMind’s Isomorphic Labs.

For now, details are limited. Anthropic has not said which diseases it will target first, whether it will work with labs or pharma partners, or what it would do if it finds a promising drug candidate.

Experts say “AI drug discovery” can mean many things.

AI can help find new molecules, analyse data, support trials and speed up research. But it cannot replace lab testing, human oversight or clinical trials.

AI can make parts of drug discovery faster, but medicine still takes years to test safely. New treatments must prove they work in the real world before reaching patients.

In short:

Molecules, meet models

Anthropic seems to be building its life sciences team, but any real results are likely years away.

No AI-designed drug has yet gone through clinical trials and reached the market.

AI may help scientists search faster, but drugs still need to pass the real-world test.

No AI-made drug has reached the market yet, so maybe keep the champagne corked and the lab budget very, very open.- MG

Mindstream Picks

Health: A once-daily Wegovy weight-loss pill has launched in UK pharmacies, offering a needle-free alternative to injections, though it is not yet available on the NHS.

Gaming: Indie title The Lonely Helmet will be delisted from Steam at the end of July, but players can keep it forever by adding it to their library before then.

Movies: Minions & Monsters topped the box office on debut but delivered the weakest opening weekend in the Despicable Me franchise despite strong reviews.

Don’t Miss: Microsoft is cutting around 1,600 Xbox jobs as part of a broader restructuring, with plans to reduce the division's workforce by 20 percent by 2027. The overhaul also includes spinning off four game studios and refocusing Xbox on larger franchises, AI, and a leaner operating model.

AI Art

Image of the Day

Daily Image Prompt

Submit your artwork to Mindstream →

Yesterday’s Poll

“What's worse: Amodei's email or Hegseth's social media response?”

Amodei's email = cold and final. - 13%

Hegseth's post = petty and public. - 87% ✅

Your Views:

“It makes me trust Anthropic and any company working with the US defense less” - saksh

“Wish their were more people like Amodei, willing to walk away from a deal that is not in service of the greater good” - r-t-m

“Both won. Hegseth’s response was full disclosure which the markets would want. I don’t see it as pretty just fine we can’t work with you and the public should know that. Do you think the governments position should have been kept a secret?” - rdhar

Submit your opinions in our polls to be featured!